Researchers in the US and Denmark have made a breakthrough in image-guided targeting of prostate tumors during arc radiotherapy treatments. In research partially supported by Varian Medical Systems (NYSE: VAR), physicists at Stanford University (California, USA) and Aarhus University Hospital (Aarhus, Denmark) have devised a method for ‘real-time’ tracking of the prostate motion using Varian’s On-Board Imager?® that shows promise in paving the way for advanced clinical treatments.
Arc therapy techniques such as Varian’s RapidArc?® technology are fast and efficient radiotherapy treatments delivered in a continuous rotation of the treatment machine around the patient. The position of the target must be updated in real-time in order for the dynamic multi-leaf collimator (DMLC) to track tumor motion. To date, a combination of MV portal images and kV orthogonal images have been tested to achieve this.
"Acquiring mega-voltage images is not ideal during RapidArc because the DMLC can block the view of the target during the treatment," says Per Rugaard Poulsen, lead author of the research. "The kV image beam is not obscured by the treatment DMLC making the markers visible from all treatment angles, unlike with the MV beam."
To test the system, arc radiotherapy was delivered to a ‘motion phantom’ implanted with fiducial markers while continuously imaging with the kV beam. The target position was determined from these images, acquired from different projections during the arc, enabling the researchers to determine information about its 3D motion. This single imager based DMLC tracking system was shown to have sub-millimeter accuracy for most types of prostate motion. Precise alignment of the treatment beam with the tumor position is vital in radiotherapy treatments, as it can reduce the likelihood of complications due to the treatment.
"The results confirm what has been seen in simulation studies and show that the method is very robust to experimental uncertainties," adds Per Rugaard Poulsen. "We’ve demonstrated that image-based tracking during arc radiotherapy can be done completely without MV images, which is an important step along the way to image-based tracking during arc treatment delivery."
Corey Zankowski, Varian’s senior director of product management, said, "This research paves the way for real-time tracking of the DMLC with tumor motion during advanced arc therapy treatments, which should allow clinicians to reduce treatment margins around the tumor. Varian is committed to working closely with industry experts and researchers to enhance treatment accuracy with the goal of improving treatment outcomes."
SOURCE Varian Medical Systems, Inc.
Posted in: Men’s Health News | Device / Technology News | Medical Procedure News
ASTRO: Sexual function does not decline in prostate cancer patients receiving EBRTSexual function in prostate cancer patients receiving external beam radiation therapy (EBRT) decreas…Children exposed to lead and tobacco are 2.4 times more likely to have ADHDChildren exposed prenatally to tobacco smoke and during childhood to lead face a particularly high r…Public information about breast screening in UK has serious shortcomingsThe information about breast screening sent to women in the United Kingdom has serious shortcomings …Liver cancer patients with high serum levels of hepatitis B virus face poorer outcomesIn the June issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American …A little anxiety can be a good thing when it comes to cancer symptomsA little anxiety can be a good thing when it comes to cancer symptoms according to researchers at Wa…
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Hong Kong S.A.R.
Macao S.A.R.
U.A.E.

News-Medical.Net provides this medical information service in accordance
with these terms and conditions.
between patient and physician/doctor and the medical advice they may provide.
Allergy Antibody Asthma Biotechnology Blood Pressure Bone Brain Breast Cancer Cancer Cardiovascular Disease Cell Chemotherapy Diabetes Diet DNA Education Exercise Health and Human Services Health Insurance Health Reform Hormone Hospital Immunology Investment Medicaid Medicare Mental Health Metabolism Neurology Nursing Nutrition Obesity Oncology Pediatrics Radiology Stress Stroke Ultrasound Vaccine Virus
Report on the use of imaging techniques in women with breast and gynecologic pathologyEnigma Diagnostics opens new Regional HQ office in San DiegoAB SCIEX collaborates with Mass Spectrometry Centre to improve drug discovery and developmentChemicals that replace ozone-destroying chlorofluorocarbons may not be eco-friendlyWatson Pharmaceuticals to acquire U.S. rights to Columbia’s bioadhesive progesterone gel productsMicromet reports total revenues of $4.6M for three months ended December 31, 2009PHC opens ten-bed adolescent unit at SHBI in Nevada’Fake pot’ can cause hallucinations and seizuresU.S. market for hearing aids and audiology devices to exceed $7 billion by 2016Sesame Workshop and AmeriChoice to develop bilingual education outreach program
Oxidative Stress and AntioxidantsOxidative Stress and OxidantsOxidative Stress EffectsWhat is Oxidative Stress?Obstructive Sleep Apnea PrognosisObstructive Sleep Apnea TreatmentsObstructive Sleep Apnea DiagnosisObstructive Sleep Apnea PathophysiologyObstructive Sleep Apnea CausesObstructive Sleep Apnea Symptoms